[Federal Register Volume 64, Number 107 (Friday, June 4, 1999)]
[Notices]
[Page 30046]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-14161]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, ``Compound Identification and Operations Support''.
    Date: June 24, 1999.
    Time: 9:00 am to 5:00 pm.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, 
MD 20814.
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, 6001 Executive Boulevard, Room 3158. 
MSC 9547, Bethesda, MD 20892-9547, (301) 435-1439.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, ``Administrative Coordinating Center for Clinical 
Trials Network''.
    Date: June 29, 1999.
    Time: 9:00 am to 5:00 pm.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, 
MD 20814.
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, 6001 Executive Boulevard, Room 3158. 
MSC 9547, Bethesda, MD 20892-9547, (301) 435-1439.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientists 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: May 28, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-14161 Filed 6-3-99; 8:45 am]
BILLING CODE 4140-01-M